Skip to content

Clinical trials

Hyperlipidemias trials in South Korea with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Unknown status Country / region: South Korea Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20132
20141
20151
20161
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hanmi Pharmaceutical Company Limited2
Alvogen Korea1
Chonbuk National University Hospital1
DongKoo Bio & Pharma1
HK inno.N Corporation1
IlDong Pharmaceutical Co Ltd1
Korea University Anam Hospital1
Sang Hak Lee1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias10
Hypertension3
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Dyslipidemias1
Hyperlipoproteinemia Type II1
Hypertriglyceridemia1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.